NCT05528445

Brief Summary

This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through EEG recordings while listening to an auditory cognitive assessment tool and preforming tasks. EEG recordings will be analyzed using proprietary computational analyses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 31, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 6, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2023

Completed
8 months until next milestone

Results Posted

Study results publicly available

May 6, 2024

Completed
Last Updated

May 6, 2024

Status Verified

August 1, 2022

Enrollment Period

1.2 years

First QC Date

August 29, 2022

Results QC Date

November 16, 2023

Last Update Submit

November 16, 2023

Conditions

Keywords

CognitionNeurologyEEGNeurosteer

Outcome Measures

Primary Outcomes (1)

  • Correlation Between Cognition Level Changes as Evaluated by Current Clinical Tools (i.e. MMSE, MoCA) and Brain Activity Features Extracted Using the Neurosteer Technology.

    Cognition level changes will be evaluated by: 1. Mini Mental State Examination (MMSE). A commonly used assessment tool that evaluates cognitive functioning and produces a total possible score of 30 points. Patients who score below 24 are typically suspected of cognitive decline. 2. Montreal Cognitive Assessment (MoCA). A commonly used assessment tool that evaluates cognitive functioning. The maximum score is 30, with a score of 26 or higher considered cognitively healthy. 3. Neurosteer system (single channel EEG recording during cognitive auditory tasks). Using data analysis (a variant of the wavelet packet analysis and the best basis algorithm), the EEG signal is transformed into brain activity features (e.g. ST4, A0). Pearson correlation will be calculated between the mean activity of the EEG features and individual's MMSE and MoCA scores.

    MMSE and MoCA scores will be taken from previous evaluation performed in the institute. Through study completion, brain activity features will be assessed twice within 7 days using the Neurosteer EEG system.

Study Arms (1)

Patients

Patients who are assessed by the clinical staff using Mini-Mental State Exam (MMSE) and Montreal-Cognitive-Assessment-Test(MoCA)

Device: Neurosteer EEG recorder

Interventions

The system is composed of hardware and software modules that facilitate the capture and interpretation of electrophysiological data as well as enable viewing the processed data in real time and offline. An electrode patch is attached on the subject's forehead to capture the electrophysiological signal. The signal is sent via low energy Bluetooth to an EEG Monitor. The signal is then sent via Wi-Fi to the cloud where the data is stored on a HIPAA compliant server. Data analysis performed in the cloud transforms the electrophysiological signal into easily readable data of brain activity.

Patients

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is comprised of patients from the inpatient rehabilitation department at Dorot Geriatric Medical Center.

You may qualify if:

  • Men and women over the age of 50.
  • MMSE ≥ 10
  • Patient is able to collaborate.
  • No seizure events.

You may not qualify if:

  • Advanced stage of cognitive decline (MMSE \< 10).
  • Any verbal or non-verbal form of objection from patient or form patient's family member or significant other.
  • Significant hearing impairments.
  • Significant vision impairments.
  • Damage to integrity of scalp and/or skull.
  • Skin irritation in the facial and forehead area.
  • Epilepsy or seizure activity.
  • History of drug abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dorot - Netanya Geriatric Medical Center

Netanya, 42420, Israel

Location

Related Publications (3)

  • Molcho L, Maimon NB, Regev-Plotnik N, Rabinowicz S, Intrator N, Sasson A. Single-Channel EEG Features Reveal an Association With Cognitive Decline in Seniors Performing Auditory Cognitive Assessment. Front Aging Neurosci. 2022 May 30;14:773692. doi: 10.3389/fnagi.2022.773692. eCollection 2022.

    PMID: 35707705BACKGROUND
  • Maimon NB, Bez M, Drobot D, Molcho L, Intrator N, Kakiashvilli E, Bickel A. Continuous Monitoring of Mental Load During Virtual Simulator Training for Laparoscopic Surgery Reflects Laparoscopic Dexterity: A Comparative Study Using a Novel Wireless Device. Front Neurosci. 2022 Jan 20;15:694010. doi: 10.3389/fnins.2021.694010. eCollection 2021.

    PMID: 35126032BACKGROUND
  • Curcic J, Vallejo V, Sorinas J, Sverdlov O, Praestgaard J, Piksa M, Deurinck M, Erdemli G, Bugler M, Tarnanas I, Taptiklis N, Cormack F, Anker R, Masse F, Souillard-Mandar W, Intrator N, Molcho L, Madero E, Bott N, Chambers M, Tamory J, Shulz M, Fernandez G, Simpson W, Robin J, Snaedal JG, Cha JH, Hannesdottir K. Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study. JMIR Res Protoc. 2022 Aug 10;11(8):e35442. doi: 10.2196/35442.

    PMID: 35947423BACKGROUND

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Results Point of Contact

Title
Nathan Intrator, Prof.
Organization
Neurosteer

Study Officials

  • Ady Sasson

    Dorot, Geriatric Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2022

First Posted

September 6, 2022

Study Start

May 31, 2022

Primary Completion

August 27, 2023

Study Completion

August 27, 2023

Last Updated

May 6, 2024

Results First Posted

May 6, 2024

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations